about
DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, SpainGenetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic reviewImmunologic response to different determinants of benzylpenicillin, amoxicillin, and ampicillin. Comparison between urticaria and anaphylactic shockSynergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patientsDifferential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.Dendrimers as carrier protein mimetics for IgE antibody recognition. Synthesis and characterization of densely penicilloylated dendrimers.Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis.High prevalence of lipid transfer protein sensitization in apple allergic patients with systemic symptoms.Cephalosporin chemical reactivity and its immunological implications.HLA class II and response to interferon-beta in multiple sclerosis.Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins.Data collectors' field journals as tools for research.Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugsImmediate allergic reactions to betalactams: facts and controversies.Drug hypersensitivity: insights into pathomechanisms.Monitoring the acute phase response in non-immediate allergic drug reactions.Immediate hypersensitivity reactions to penicillins and other betalactams.Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizoleNonimmediate reactions to betalactams.Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone.FCERI and Histamine Metabolism Gene Variability in Selective Responders to NSAIDSThe influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams.Update on the evaluation of hypersensitivity reactions to betalactams.Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests.LPS promotes Th2 dependent sensitisation leading to anaphylaxis in a Pru p 3 mouse model.Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.Metabolomics in drug intolerance.In vitro diagnosis of immediate allergic reactions to drugs: an update.The in vitro diagnosis of drug allergy: status and perspectives.Role of dendritic cells in drug allergy.Food allergy: management, diagnosis and treatment strategies.Advanced phenotyping in hypersensitivity drug reactions to NSAIDs.Hypersensitivity reactions to beta-lactams.Prediction of hypersensitivity to antibiotics: what factors need to be considered?Contributions of pharmacogenetics and transcriptomics to the understanding of the hypersensitivity drug reactions.Recommendations for the use of in vitro methods to detect specific immunoglobulin E: are they comparable?Allergic reactions to antibiotics in children.Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity.Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double-blind placebo-controlled clinical trial.Hypersensitivity reactions to β-lactams: relevance of hapten-protein conjugates.
P50
Q28256349-31A883D0-A736-4009-8081-0A8045C356D3Q28271185-8A7DEB48-F985-4643-B38F-F7C5DA641E9DQ28373397-56AEF262-C49E-4A31-8D0A-CF681D916A72Q28533519-F7BAB8C8-8B39-4FDA-B936-69D0DB21BAD3Q30402227-A8040B11-0D78-46BB-BF04-1C3BCB736A04Q30708677-0D863B51-1DFB-40B8-96E8-815000AF4883Q33734529-44439D6E-BFD7-4C9F-A5EB-44CAB96E9E4DQ34166342-B6B04187-E140-44DB-9551-D94D44288372Q34429739-A17EF59B-72B1-4D8A-9E5C-5B19659244D0Q34466703-C271CEE6-DD35-445B-9035-31A8C7DF0281Q34564689-89C7017C-C0C3-4164-B449-1CC9C5E776A2Q35029366-06D923E1-CC0C-4BD1-B9C2-CB95887C0925Q35117697-E003F030-4674-4961-8862-DB55DA4D99F9Q35828362-B518783E-82F2-472D-A9C4-A58719EA538AQ36255144-F85CF2C3-CA0B-473E-B775-06BEB2A7425EQ36529584-56A2CAB9-07DE-4751-8128-FB698AE22D53Q36612017-2A4FB191-D642-4818-AD76-C2A394489456Q36748349-02544B89-58AA-4121-8065-4ADBAC7A024BQ36874716-518333E3-BDF3-4D69-8924-6968F32205F5Q37003616-237B816E-0151-488A-890D-EAD974E55695Q37293225-E9EC8C25-E80D-4FA4-840E-D7D94ACCBD2AQ37330476-29661F90-D2C9-4210-869D-A546BA707598Q37365661-108C2B05-2B26-44E9-80E5-A6E75CC90C69Q37498681-3850048C-917F-485E-9E36-082C63E142D8Q37584534-D3FAA0A3-D11A-406B-8C4D-D31A9D275511Q37695437-8AA2218C-9AA1-4C9D-A64B-D58422C86B79Q37705496-8E4E4B38-C70C-4A3B-B852-F759013E2DB3Q37749734-F464C27E-13E1-4604-ABC5-5FAD8B6FE533Q37885398-07456E6D-8E3C-4B6E-9D0D-53582ADC5B63Q37887437-01A5A497-0AAB-4051-AC27-0E8C420394A0Q38119552-871EF895-DAFC-4D1F-A6E8-5C2D5F1196ADQ38145527-A633E6B5-3D67-48A7-A14B-62D994149049Q38161485-A05D07A4-5C31-44EE-A8DC-2355F654568BQ38161564-9B51DAD1-49BE-4E0D-B56C-EE76E362E3A3Q38182188-2C1C7428-A6DE-48B1-9951-6FCDD15C08D2Q38198050-AE4C1D4A-4215-4A38-9612-B936435C73E0Q38213462-F17354C5-A9DC-4588-BC00-E1A2999511C8Q38228069-DD90DC98-7AE6-4F48-92B5-7F59F410CB17Q38394433-3B570A3E-2301-4BF8-AAE3-37147B4F41CAQ38433193-9906C02D-041C-4CFC-96FA-1BE42FEC0C22
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristobalina Mayorga
@ast
Cristobalina Mayorga
@en
Cristobalina Mayorga
@es
Cristobalina Mayorga
@nl
type
label
Cristobalina Mayorga
@ast
Cristobalina Mayorga
@en
Cristobalina Mayorga
@es
Cristobalina Mayorga
@nl
prefLabel
Cristobalina Mayorga
@ast
Cristobalina Mayorga
@en
Cristobalina Mayorga
@es
Cristobalina Mayorga
@nl
P106
P31
P496
0000-0001-8852-8077